The İzmir International Biomedicine and Genome Institute commenced its activities following the renaming of the Hemodialysis–Transplantation Institute, which had been operating under the Rectorate of Dokuz Eylül University, to the İzmir International Biomedicine and Genome Institute, in accordance with Decision No. 2015/7321 adopted by the Grand National Assembly of Türkiye on 16/02/2015 and published in the Official Gazette of the Republic of Türkiye dated 9 March 2015, No. 29290.

Pursuant to the Senate Decision dated 07/04/2015 and numbered 439, and the decision of the Executive Board of the Council of Higher Education (YÖK) dated 28/04/2015, the Departments of Genome Sciences and Molecular Biotechnology and of Biomedicine and Health Technologies were established.

At the meeting of the YÖK Executive Board held on 10/08/2016, it was approved to open the Molecular Biology and Genetics Master’s Program (with Thesis, English) and the Doctoral Program (English) within the Department of Genome Sciences and Molecular Biotechnology.

By the decision of the YÖK Executive Board dated 26/08/2020, the Master’s Program in Biomedicine and Health Technologies (with Thesis, English) and the Doctoral Program in Biomedicine and Health Technologies (English) were established within the Department of Biomedicine and Health Technologies.

Having started its educational activities in 2015, the İzmir International Biomedicine and Genome Institute continues its operations with a steadily increasing student capacity and expanding academic activities.

Administrators Who Have Served Since the Establishment

Prof. Dr. Şermin GENÇ  02.09.2025 –

Prof. Dr. İ. Mehmet Ali ÖKTEM 25.02.2021 – 02.09.2025

Prof. Dr. Sefa KIZILDAĞ  20.02.2018 – 20.02.2021

Prof. Dr. Mehmet ÖZTÜRK  14.02.2018 – 09.05.2025